-
Cangene Corporation was a
biopharmaceutical company based in Winnipeg, Manitoba, Canada. It was
founded in 1984 and
specialized in hyperimmunes, contract...
- (trade name BAT), made by
Emergent BioSolutions Canada Inc. (formerly
Cangene Corporation) – is a licensed,
commercially available botulism anti-toxin...
- (IVIG). [WinRho SDF is an anti-D manufactured,
distributed and
marketed by
Cangene in the US.
There is a
black box
warning on
WinRho SDF due to the risk of...
-
Apotex owned 61% of
Cangene Corp., a Winnipeg-based
biopharmaceutical company,
according to
Cangene's 2007
annual report.
Cangene's business focuses are...
-
Boehringer Mannheim (1817—1997)
Cambridge Antibody Technology (1989–2007)
Cangene (1984–2014)
CareFusion (2009–2015)
Celltech (1980–2004)
Cephalon (1987–2011)...
- is a
research &
laboratory and cGMP-production facility.
Developed by
Cangene in 1982 with
additions in 2003 and 2006, it was
purchased in 2014 by Emergent...
-
Copper Basic materials Nonferrous metals Vancouver 1997
Copper mining Cangene Corp.
Health care
Biotechnology Winnipeg 1984 Biotech,
defunct 2014 CanJet...
- that
lasted up to 8 hours.
Episil oral
liquid is
marketed in the US by
Cangene. In a 2012
randomized controlled pilot study involving pediatric patients...
- bacteria.
BARDA also
supported the
development of the
antitoxins Anthrasil of
Cangene (March 2015 FDA approval) and
Anthim of
Elusys Therapeutics (March 2016...
- in
combination with
antibiotics to
treat anthrax. It was
developed by
Cangene and
purchased in 2011 by the
Biomedical Advanced Research and Development...
